PHI with Menopause

How does this condition affect your private health insurance?

Klimakterium, commonly known as menopause, marks the natural biological transition in a woman's life when menstrual periods permanently stop, signifying the end of reproductive years. It is clinically defined as 12 consecutive months without a menstrual period. This phase is characterized by a significant decline in ovarian hormone production, primarily estrogen and progesterone, leading to a range of physical and emotional symptoms. These can include hot flashes, night sweats, sleep disturbances, mood swings, vaginal dryness, and bone density loss. While a natural process, its symptoms and long-term health implications often require management.

PKV Risk Assessment

High Probability of Rejection

However, some specialized PHI providers may insure you with a surcharge of up to 5%.

This is a preliminary assessment. For a detailed and binding risk assessment, .

Impact on Your Insurance Policy

Duration of Illness (Initial)

Perimenopause, the transition phase leading to menopause, typically lasts 4-8 years, with symptom onset varying greatly among individuals.

Duration of Illness (Lifetime)

The menopausal state is permanent; once menopause is reached, reproductive function ceases. Symptom management may be ongoing for many years post-menopause.

Cost of Treatment (Initial)

Highly variable, ranging from minimal for lifestyle changes (e.g., 50-200 USD for supplements/initial doctor visits) to moderate for hormonal therapy (e.g., 300-1500 USD per year, including consultations and medication), depending on insurance and chosen interventions.

Cost of Treatment (Lifetime)

Significant, especially if managing long-term health risks like osteoporosis and cardiovascular disease. This can range from several hundred to thousands of USD annually for ongoing medical check-ups, bone density screenings, hormonal therapy, and medications for associated conditions.

Mortality Rate

Menopause itself is not a cause of death. However, the associated long-term estrogen deficiency increases the risk of cardiovascular disease and osteoporosis, which can indirectly contribute to mortality. The direct probability of death from menopause is negligible.

Risk of Secondary Damages

High. Secondary damages include increased risk of osteoporosis (leading to fractures), cardiovascular disease, urogenital atrophy (vaginal dryness, urinary issues), mood disorders (depression, anxiety), sleep disturbances, and cognitive changes.

Probability of Full Recovery

Menopause is a natural, irreversible physiological process, not an illness from which one 'recovers.' Symptoms can be managed and mitigated, but the hormonal changes and end of reproductive function are permanent.

Underlying Disease Risk

Menopause is not caused by underlying diseases but can expose or exacerbate pre-existing conditions or increase the risk for new ones due to hormonal changes. Examples include an increased likelihood of developing osteoporosis, heart disease, or exacerbation of mood disorders.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.